I'd like to send this parcel to healthland pharmacy columbus ohio The company said that while its treatment, NKTR-181, performed as expected as an opioid analgesic throughout the study with patients continuing to show a reduction in pain scores throughout the randomized phase of the study as well, patients who took the placebo didn't show the expected increase in pain scores observed in similar withdrawal studies.